Abstract:Highlights • Novel dual-functional sensor: Laser-induced graphene (LIG) & gold nanoparticles (AuNPs) for enhanced detection. • SERS substrate detects target molecule with 10 -7 M limit, enabling 10 -3 M detection of creatinine and uric acid, and 10 -4 M for urea. • Stable sensor with distinct, concentration-dependent CV responses to uremic toxins. • This novel approach promises point-of-care kidney diagnostics and early disease intervention. Background Chronic kidney disease (CKD) leads to uremic toxin buildup, requiring early detection for better management. Existing methods lack sensitivity, speed, or affordability for point-of-care diagnosis. This work addresses this by creating a novel sensor for rapid, sensitive uremic toxin detection. Methods The sensor leverages the combined effects of surface-enhanced Raman scattering (SERS) and electrochemistry (EC) for superior detection. The LIG substrate provides a stable platform for AuNPs, facilitating interaction with target molecules. Additionally, electrochemical deposition optimizes the sensor's sensitivity by amplifying the local electromagnetic field around AuNPs and offering specific binding sites for uremic toxins. Significant findings The developed sensor demonstrates exceptional performance in detecting uremic toxins. It achieves remarkably low detection limits (10 -3 M for creatinine/uric acid, 10 -4 M for urea) and offers distinct, concentration-dependent responses for different toxins in cyclic voltammetry (CV) measurements. Furthermore, characteristic oxidation peaks at specific potentials allow for direct identification and quantification of the toxins. These findings highlight the immense potential of this cost-effective and scalable sensor for point-of-care diagnostics and remote monitoring of kidney function. This advancement can significantly improve patient care by facilitating early detection of kidney problems and enabling timely intervention. Graphical abstract This work describes a novel sensor for rapid detection of uremic toxins (creatinine, uric acid, urea) using a flexible platform combining laser-induced graphene (LIG) and gold nanoparticles (AuNPs). The sensor leverages SERS and electrochemistry for sensitive identification and quantification. LIG offers a robust support for AuNPs, and electrochemical deposition enhances sensitivity. The sensor detects toxins at low concentrations (10-3 M for creatinine/uric acid, 10-4 M for urea) and shows distinct responses in CV measurements. This cost-effective platform holds promise for point-of-care diagnostics and remote kidney function monitoring. Download: Download high-res image (161KB) Download: Download full-size image

Advancements in Amperometric Biosensing Instruments for Creatinine Detection: A Critical Review

A Disposable Printed Amperometric Biosensor for Clinical Evaluation of Creatinine in Renal Function Detection

Smartphone-based Portable Photoelectrochemical Biosensing System for Point-of-care Detection of Urine Creatinine and Albumin

Electrochemical Sensors for Clinic Analysis

Electrochemical Creatinine (Bio)Sensors for Point-of-Care Diagnosis of Renal Malfunction and Chronic Kidney Disorders

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

Multi-Parameter Detection of Urine Based on Electropolymerized PANI: PSS/AuNPs/SPCE

Electrochemical Protein-Based Biosensors for Creatine Kinase: A Review

Selective Detection of Creatinine Using Enzymatic Route for Diagnosis of Chronic Kidney Diseases

Zwitterion-Functionalized Cuprous Oxide Nanoparticles for Highly Specific and Enzymeless Electrochemical Creatinine Biosensing in Human Serum

Point-of-care testing device platform for the determination of creatinine on an enzyme@CS/PB/MXene@AuNP-based screen-printed carbon electrode

Electrochemically deposited Au nano-island on laser-scribed graphene substrates as EC-SERS biochips for uremic toxins detection

Sensitive electrochemical detection of creatinine based on electrodeposited Molecular Imprinting Polymer modified screen printed carbon electrode

Recent advances in wearable biosensors for non-invasive monitoring of specific metabolites and electrolytes associated with chronic kidney disease: Performance evaluation and future challenges

High-Performance Electrochemical Creatinine Sensors Based on β-Lead Dioxide/Single-Walled Carbon Nanotube Electrodes

Portable Electrochemical System and Platform with Point-of-Care Determination of Urine Albumin-to-Creatinine Ratio to Evaluate Chronic Kidney Disease and Cardiorenal Syndrome

Nitrogen doped carbon dots and gold nanoparticles mediated FRET for the detection of creatinine in human urine samples

Ultrasensitive colorimetric detection of creatinine via its dual binding affinity for silver nanoparticles and silver ions

A Simple and Efficient Colorimetric Detection of Creatinine Based on Citrate-Stabilized Gold Nanoparticles

Boron nitride nanotube-based creatinine biosensors for athlete physical condition monitoring

Software Integrated Personalized Biosensing Device for Serum Creatinine Detection Based on Boron doped MXene Nanohybrid